STK19 was previously identified in two cancer genomics studies of genes that are frequently mutated in melanoma patients (Hodis et al., 2012, Lawrence et al., 2014), making its role in the transcription-related DNA damage response particularly exciting. The gene discussed is WHR1; the disease is cancer.